Cargando…

circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer

CircRNAs (circRNAs) are a kind of non-coding RNAs which are extensively distributed in tissues. Previous investigations reported that circRNAs harbor indispensable roles in modulating the progress of multiple cancers. Nevertheless, the function along with the molecular mechanism of most circRNAs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Peng, Qin, Jing, Liu, Lingyan, Tan, Wupeng, Lei, Linchen, Zhu, Jiayu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320557/
https://www.ncbi.nlm.nih.gov/pubmed/35779530
http://dx.doi.org/10.18632/aging.204152
_version_ 1784755821430702080
author Wu, Peng
Qin, Jing
Liu, Lingyan
Tan, Wupeng
Lei, Linchen
Zhu, Jiayu
author_facet Wu, Peng
Qin, Jing
Liu, Lingyan
Tan, Wupeng
Lei, Linchen
Zhu, Jiayu
author_sort Wu, Peng
collection PubMed
description CircRNAs (circRNAs) are a kind of non-coding RNAs which are extensively distributed in tissues. Previous investigations reported that circRNAs harbor indispensable roles in modulating the progress of multiple cancers. Nevertheless, the function along with the molecular mechanism of most circRNAs in cervical cancer progression was still not clear. Herein, we illustrated that circEPSTI1 is a remarkably upregulated circRNA, which we validated in tissues with cervical cancer along with cell lines. The biological role of circEPSTI1 in the advancement of cervical cancer was probed via loss-of function assessments. Silencing circEPSTI1 could diminish the proliferative capacity of the cervical cancer cells to spread. In cervical cancer cells, silencing circEPSTI1 dramatically elevated drug responsivity to cisplatin. Mechanically, RNA immuno-precipitation experiments and dual luciferase enzyme reporter experiments were conducted to reveal the molecular mechanism of circEPSTI1 in cervical cancer. In conclusion, this research premise identified the biological function of circEPSTI1-miR-370-3p-MSH2 axis in cervical cancer progression. Our result is significant for slowing the progress of and overcoming drug resistance of cervical cancer.
format Online
Article
Text
id pubmed-9320557
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-93205572022-07-27 circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer Wu, Peng Qin, Jing Liu, Lingyan Tan, Wupeng Lei, Linchen Zhu, Jiayu Aging (Albany NY) Research Paper CircRNAs (circRNAs) are a kind of non-coding RNAs which are extensively distributed in tissues. Previous investigations reported that circRNAs harbor indispensable roles in modulating the progress of multiple cancers. Nevertheless, the function along with the molecular mechanism of most circRNAs in cervical cancer progression was still not clear. Herein, we illustrated that circEPSTI1 is a remarkably upregulated circRNA, which we validated in tissues with cervical cancer along with cell lines. The biological role of circEPSTI1 in the advancement of cervical cancer was probed via loss-of function assessments. Silencing circEPSTI1 could diminish the proliferative capacity of the cervical cancer cells to spread. In cervical cancer cells, silencing circEPSTI1 dramatically elevated drug responsivity to cisplatin. Mechanically, RNA immuno-precipitation experiments and dual luciferase enzyme reporter experiments were conducted to reveal the molecular mechanism of circEPSTI1 in cervical cancer. In conclusion, this research premise identified the biological function of circEPSTI1-miR-370-3p-MSH2 axis in cervical cancer progression. Our result is significant for slowing the progress of and overcoming drug resistance of cervical cancer. Impact Journals 2022-07-02 /pmc/articles/PMC9320557/ /pubmed/35779530 http://dx.doi.org/10.18632/aging.204152 Text en Copyright: © 2022 Wu et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Wu, Peng
Qin, Jing
Liu, Lingyan
Tan, Wupeng
Lei, Linchen
Zhu, Jiayu
circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
title circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
title_full circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
title_fullStr circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
title_full_unstemmed circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
title_short circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer
title_sort circepsti1 promotes tumor progression and cisplatin resistance via upregulating msh2 in cervical cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320557/
https://www.ncbi.nlm.nih.gov/pubmed/35779530
http://dx.doi.org/10.18632/aging.204152
work_keys_str_mv AT wupeng circepsti1promotestumorprogressionandcisplatinresistanceviaupregulatingmsh2incervicalcancer
AT qinjing circepsti1promotestumorprogressionandcisplatinresistanceviaupregulatingmsh2incervicalcancer
AT liulingyan circepsti1promotestumorprogressionandcisplatinresistanceviaupregulatingmsh2incervicalcancer
AT tanwupeng circepsti1promotestumorprogressionandcisplatinresistanceviaupregulatingmsh2incervicalcancer
AT leilinchen circepsti1promotestumorprogressionandcisplatinresistanceviaupregulatingmsh2incervicalcancer
AT zhujiayu circepsti1promotestumorprogressionandcisplatinresistanceviaupregulatingmsh2incervicalcancer